Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

Similar articles for PubMed (Select 24016283)

1.

Late rebound of infantile hemangioma after cessation of oral propranolol.

Shehata N, Powell J, Dubois J, Hatami A, Rousseau E, Ondrejchak S, McCuaig C.

Pediatr Dermatol. 2013 Sep-Oct;30(5):587-91. doi: 10.1111/pde.12190.

PMID:
24016283
2.

Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.

Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M, Fischer G, Powell J, Cohen B, Ben Amitai D.

Pediatr Dermatol. 2011 Mar-Apr;28(2):94-8. doi: 10.1111/j.1525-1470.2010.01379.x. Epub 2011 Mar 1.

PMID:
21362031
3.

Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.

Bertrand J, Sammour R, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Boutin C, Bortoluzzi P, Laberge LC, Powell J.

J Cutan Med Surg. 2012 Sep-Oct;16(5):317-23.

PMID:
22971306
4.

Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.

Bertrand J, Sammour R, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Boutin C, Bortoluzzi P, Laberge LC, Powell J.

J Cutan Med Surg. 2012 Mar-Apr;16(2):115-21.

PMID:
22513064
5.

Effect of propranolol on the treatment of infantile hemangiomas: a single tertiary center 3-year experience.

Park YW, Yeom KB, Choi JW, Kim DY, Shin H, Kim KH.

J Dermatolog Treat. 2014 Oct;25(5):391-5. doi: 10.3109/09546634.2012.761667. Epub 2013 Feb 24.

PMID:
23273264
6.

Propranolol for infantile hemangiomas.

Bagazgoitia L, Torrelo A, Gutiérrez JC, Hernández-Martín A, Luna P, Gutiérrez M, Baño A, Tamariz A, Larralde M, Alvarez R, Pardo N, Baselga E.

Pediatr Dermatol. 2011 Mar-Apr;28(2):108-14. doi: 10.1111/j.1525-1470.2011.01345.x. Epub 2011 Mar 8.

PMID:
21385205
7.

Oral propranolol: an effective, safe treatment for infantile hemangiomas.

Zaher H, Rasheed H, Hegazy RA, Hegazy RA, Abdelhalim DM, Gawdat HI.

Eur J Dermatol. 2011 Jul-Aug;21(4):558-63. doi: 10.1684/ejd.2011.1372.

PMID:
21697036
8.

Low-dose propranolol for infantile haemangioma.

Tan ST, Itinteang T, Leadbitter P.

J Plast Reconstr Aesthet Surg. 2011 Mar;64(3):292-9. doi: 10.1016/j.bjps.2010.06.010. Epub 2010 Jul 7.

PMID:
20615772
9.

Propranolol and infantile hemangiomas four years later: a systematic review.

Marqueling AL, Oza V, Frieden IJ, Puttgen KB.

Pediatr Dermatol. 2013 Mar-Apr;30(2):182-91. doi: 10.1111/pde.12089. Epub 2013 Feb 14. Review.

PMID:
23405852
10.

Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.

Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T.

Acta Paediatr. 2012 Oct;101(10):e469-74. doi: 10.1111/j.1651-2227.2012.02783.x. Epub 2012 Jul 24.

PMID:
22804809
11.

Hemangiomas of the nasal tip treated with propranolol.

Ben-Amitai D, Halachmi S, Zvulunov A, Raveh E, Kalish E, Lapidoth M.

Dermatology. 2012;225(4):371-5. doi: 10.1159/000346331. Epub 2013 Feb 20.

PMID:
23428617
12.

Treatment of infantile hemangiomas with propranolol: clinical guidelines.

Szychta P, Stewart K, Anderson W.

Plast Reconstr Surg. 2014 Apr;133(4):852-62. doi: 10.1097/PRS.0000000000000007. Erratum in: Plast Reconstr Surg. 2014 Jul;134(1):168.

PMID:
24352207
13.

Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.

Zaher H, Rasheed H, Esmat S, Hegazy RA, Gawdat HI, Hegazy RA, El-Komy M, Abdelhalim DM.

Eur J Dermatol. 2013 Sep-Oct;23(5):646-52. doi: 10.1684/ejd.2013.2146.

PMID:
24135427
14.

Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.

Sadykov RR, Podmelle F, Sadykov RA, Kasimova KR, Metellmann HR.

Int J Oral Maxillofac Surg. 2013 Jul;42(7):863-7. doi: 10.1016/j.ijom.2013.03.015. Epub 2013 Apr 22.

PMID:
23618833
15.

Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.

de Graaf M, Breur JM, Raphaël MF, Vos M, Breugem CC, Pasmans SG.

J Am Acad Dermatol. 2011 Aug;65(2):320-7. doi: 10.1016/j.jaad.2010.06.048. Epub 2011 May 20.

PMID:
21601311
16.

Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.

Hermans DJ, Bauland CG, Zweegers J, van Beynum IM, van der Vleuten CJ.

Br J Dermatol. 2013 Apr;168(4):837-43. doi: 10.1111/bjd.12189.

PMID:
23278381
17.

Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.

Sagi L, Zvulunov A, Lapidoth M, Ben Amitai D.

Dermatology. 2014;228(2):136-44. doi: 10.1159/000351557. Epub 2014 Feb 15.

PMID:
24556822
18.

Propranolol for treatment of ulcerated infantile hemangiomas.

Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, Lacour JP, Naouri M, Vabres P, Hadj-Rabia S, Nguyen JM, Stalder JF, Barbarot S; Groupe de Recherche Clinique en Dermatologie Pédiatrique.

J Am Acad Dermatol. 2011 May;64(5):827-32. doi: 10.1016/j.jaad.2010.12.040. Epub 2011 Feb 25.

PMID:
21353332
19.

Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas.

Schiestl C, Neuhaus K, Zoller S, Subotic U, Forster-Kuebler I, Michels R, Balmer C, Weibel L.

Eur J Pediatr. 2011 Apr;170(4):493-501. doi: 10.1007/s00431-010-1324-2. Epub 2010 Oct 9.

PMID:
20936416
20.

The use of propranolol for complicated infantile hemangiomas.

Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P.

Int J Dermatol. 2013 Sep;52(9):1140-6. doi: 10.1111/j.1365-4632.2012.05795.x. Epub 2013 Jul 8.

PMID:
23829783
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk